[PDF][PDF] DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia
…, Y Li, C Erpelinck-Verschueren, X Deng, PJ Christos… - Cancer cell, 2010 - cell.com
We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which
reflect critical biological differences. We therefore examined the methylation profiles of 344 …
reflect critical biological differences. We therefore examined the methylation profiles of 344 …
[HTML][HTML] Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
…, A Weinberg, J Mandeli, P Christos… - Journal of clinical …, 2008 - ncbi.nlm.nih.gov
… Knox, Sean Clark-Garvey, Alan Weinberg, John Mandeli, Paul Christos, Madhu
Mazumdar, Shahin Rafii, Jonathan D. Schwartz … Knox, Helen Chen, Sean Clark-Garvey …
Mazumdar, Shahin Rafii, Jonathan D. Schwartz … Knox, Helen Chen, Sean Clark-Garvey …
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 …
…, RJ Scheff, BB Pua, JF Gruden, PJ Christos… - The Lancet …, 2021 - thelancet.com
Background Previous phase 2 trials of neoadjuvant anti-PD-1 or anti-PD-L1 monotherapy in
patients with early-stage non-small-cell lung cancer have reported major pathological …
patients with early-stage non-small-cell lung cancer have reported major pathological …
Phase II study of lutetium-177–labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
…, M Morris, S Vallabhajosula, P Christos… - Clinical cancer …, 2013 - AACR
Purpose: To assess the efficacy of a single infusion of radiolabeled anti-prostate-specific
membrane antigen (PSMA) monoclonal antibody J591 (lutetium-177; 177 Lu) by prostate-…
membrane antigen (PSMA) monoclonal antibody J591 (lutetium-177; 177 Lu) by prostate-…
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
…, D Ballon, L Heier, BM Greenwald, P Christos… - Human gene …, 2008 - liebertpub.com
Late infantile neuronal ceroid lipofuscinosis (LINCL) is an autosomal recessive, neurodegenerative
lysosomal storage disease affecting the CNS and is fatal by age 8 to 12 years. A total …
lysosomal storage disease affecting the CNS and is fatal by age 8 to 12 years. A total …
[PDF][PDF] Outcome of deferred initial therapy in mantle-cell lymphoma
P Martin, A Chadburn, P Christos, K Weil… - J Clin …, 2009 - researchgate.net
Purpose Treatment of mantle-cell lymphoma (MCL) is nonstandardized, though patients are
commonly treated immediately at diagnosis. Because data on observation, or “watch and …
commonly treated immediately at diagnosis. Because data on observation, or “watch and …
[HTML][HTML] Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
…, RS Berman, AC Pavlick, F Darvishian, P Christos… - PloS one, 2012 - journals.plos.org
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies
depends, at least in part, on the assumption that metastatic tumors are primarily clonal with …
depends, at least in part, on the assumption that metastatic tumors are primarily clonal with …
Validating the clinical assessment of eustachian tube dysfunction: the Eustachian Tube Dysfunction Questionnaire (ETDQ‐7)
ED McCoul, VK Anand, PJ Christos - The Laryngoscope, 2012 - Wiley Online Library
… Paul Christos was partially supported by the following grant: Clinical Translational Science
Center (CTSC) (UL1-RR024996). The authors have no other funding, financial relationships, …
Center (CTSC) (UL1-RR024996). The authors have no other funding, financial relationships, …
Patterns of detection in patients with cutaneous melanoma: implications for secondary prevention
MS Brady, SA Oliveria, PJ Christos… - … Journal of the …, 2000 - Wiley Online Library
BACKGROUND Despite the importance of early detection in preventing mortality from
melanoma, little is known regarding how patients with the disease come to diagnosis. METHODS …
melanoma, little is known regarding how patients with the disease come to diagnosis. METHODS …
Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved?
RM Simmons, M Brennan, P Christos, V King… - Annals of Surgical …, 2002 - Springer
Background Skin-sparing mastectomy (SSM), which involves the resection of the nipple/areolar
complex with the breast parenchyma, improves the aesthetic outcome for breast cancer …
complex with the breast parenchyma, improves the aesthetic outcome for breast cancer …